Testing for bacterial endotoxins with recombinant factor C might be included as a new general chapter in the European Pharmacopoeia. The European Pharmacopoeia has called for public consultation on the creation of a new General Chapter (2.6.32). In 2016, the Pharm. Eur. referred the rFC test as an alternative to Limulus amebocyte lysate (LAL) in Guidelines for using the test for bacterial endotoxins (Supplement 8.8 Chapter 5.1.10). The next step would be a separate chapter on testing for bacterial endotoxins using the rFC assay.